Related Research Articles
Immunostimulants, also known as immunostimulators, are substances that stimulate the immune system usually in a non-specific manner by inducing activation or increasing activity of any of its components. One notable example is the granulocyte macrophage colony-stimulating factor. The goal of this stimulated immune response is usually to help the body have a stronger immune system response in order to improve outcomes in the case of an infection or cancer malignancy. There is also some evidence that immunostimulants may be useful to help decrease severe acute illness related to chronic obstructive pulmonary disease or acute infections in the lungs.
Ian Hector Frazer is a Scottish-born Australian immunologist, the founding CEO and Director of Research of the Translational Research Institute (Australia). Frazer and Jian Zhou developed and patented the basic technology behind the HPV vaccine against cervical cancer at the University of Queensland. Researchers at the National Cancer Institute, Georgetown University, and University of Rochester also contributed to the further development of the cervical cancer vaccine in parallel.
Christopher Carl Goodnow is an immunology researcher and the current executive director of the Garvan Institute of Medical Research. He holds the Bill and Patricia Ritchie Foundation Chair and is a Conjoint Professor in the faculty of medicine at UNSW Sydney. He holds dual Australian and US citizenship.
Stefan Hugo Ernst Kaufmann is a German immunologist and microbiologist and is one of the highly cited immunologists worldwide for the decade 1990 to 2000. He is amongst the 0.01% most cited scientists of c. 7 million scientists in 22 major scientific fields globally.
Francesco Dieli is an Italian immunologist. He was born in Prizzi, Italy. After high school education, in 1983 he got his degree with honors in Medicine at the University of Palermo where he specialized in Pathology. He got his PhD in Immunology in 1999. He is full professor of Immunology and Director of the Division of Immunology and Immunogenetics at the University of Palermo, Italy.
Akiko Iwasaki is a Sterling Professor of Immunobiology and Molecular, Cellular and Developmental Biology at Yale University. She is also a principal investigator at the Howard Hughes Medical Institute. Her research interests include innate immunity, autophagy, inflammasomes, sexually transmitted infections, herpes simplex virus, human papillomavirus, respiratory virus infections, influenza infection, T cell immunity, commensal bacteria, COVID-19, and long COVID.
Barry R. Bloom is Joan L. and Julius H. Jacobson Professor of Public Health, Emeritus in the Department of Immunology and Infectious Diseases and Department of Global Health and Population in the Harvard T.H. Chan School of Public Health, where he served as dean of the faculty from 1998 through December 31, 2008.
Ursula Wiedermann is an Austrian medical scientist who has made significant contributions in the field of allergies and of cancer immunotherapy. She is currently Professor of Vaccinology at the Medical University of Vienna. Wiedermann's work in the field of B cell peptide vaccines led to the creation of HER-Vaxx, an immunotherapy for the treatment of HER-2-positive cancers. This vaccine is currently being taken into mid-stage clinical development in gastric cancer by the biotech company Imugene, where Wiedermann is Chief Scientific Officer.
Niki M. Moutsopoulos is a Greek periodontist and immunologist. She is a senior investigator in the oral immunity and infection section at the National Institute of Dental and Craniofacial Research. Moutsopoulos specializes in oral immunology and periodontitis. Her research program focuses on host-microbial interactions that can drive chronic inflammatory responses and tissue destruction in the oral cavity.
Donna Elizabeth Davies is a British biochemist and professor of respiratory cell and molecular biology at the University of Southampton. In 2003, Davies was the co-founder of Synairgen, an interferon-beta drug designed to treat patients with asthma and chronic obstructive pulmonary disease.
A nasal vaccine is a vaccine administered through the nose that stimulates an immune response without an injection. It induces immunity through the inner surface of the nose, a surface that naturally comes in contact with many airborne microbes. Nasal vaccines are emerging as an alternative to injectable vaccines because they do not use needles and can be introduced through the mucosal route. Nasal vaccines can be delivered through nasal sprays to prevent respiratory infections, such as influenza.
Michael Joseph Mina is an American epidemiologist, immunologist and physician. He was formerly an assistant professor of Epidemiology & Immunology and Infectious Diseases at Harvard T.H. Chan School of Public Health, assistant Professor of Pathology at Brigham and Women's Hospital, Harvard Medical School, and currently Chief Medical Officer at eMed. and Chief Medical and Science Officer at Oncodea.
A viral vector vaccine is a vaccine that uses a viral vector to deliver genetic material (DNA) that can be transcribed by the recipient's host cells as mRNA coding for a desired protein, or antigen, to elicit an immune response. As of April 2021, six viral vector vaccines, four COVID-19 vaccines and two Ebola vaccines, have been authorized for use in humans.
Noora is a COVID-19 vaccine candidate developed by Baqiyatallah University of Medical Sciences in collaboration with Plasma Darman Sarv Sepid Co. in Iran. Introduced in June 2021, it was announced as having "successfully passed the first phase of its clinical trial" two months later.
Maree Gleeson is an Australian immunologist. Her research has focused on respiratory immunology in children and elite athletes. She has held multiple leadership positions within the health sector in the Hunter Region in NSW.
Daniela M. Ferreira is a Brazilian British immunologist. She is a specialist in bacterial infection, respiratory co-infection, mucosal immunology and vaccine responses. She is currently Professor of Respiratory Infection and Vaccinology at the Oxford Vaccine Group in the Department of Paediatrics at the University of Oxford and the Director of the Liverpool Vaccine Group at the Liverpool School of Tropical Medicine. She leads a team of scientists studying protective immune responses against pneumococcus and other respiratory pathogens such as SARS-CoV2. Her team has established a novel method of inducing pneumococcal carriage in human volunteers. They use this model to:
Alessandra Alberta Pucci is an Australian immunologist and entrepreneur who founded and led Australian Monoclonal Development, the first biotechnology company in Australia.
Graeme John Stewart,, MB BS, PhD, FRACP, FRCPA is an Australian consultant physician, medical researcher in the field of immunology, and a community health advocate. He is Clinical Professor of Medicine in the Westmead Institute for Medical Research, University of Sydney.
De’Broski. R. Herbert is an immunologist, parasitologist, academic, and biomedical researcher. He ẁas appointed Professor of Immunology in 2021, and Penn Presidential Professor at the University of Pennsylvania School of Veterinary Medicine. He is also the Associate Director for Institute of Infectious and Zoonotic Disease (PennVet), and an affiliated Scientist at the Monell Chemical Senses Center.
Dr. Nimesh Gupta, an Indian vaccine immunologist, is a senior scientist and the Chief of the Vaccine Immunology Laboratory at the National Institute of Immunology in India. He has done research on understanding the T-cell determinants of long-term and broadly protective immunity against virus infection and vaccination. In addition to his research, Dr. Gupta has established a Human Immune Monitoring and T-cell Assay Platform for vaccine evaluation.
References
- ↑ Clancy, RL (2012). "Towards a vaccine for chronic obstructive pulmonary disease". Intern Med J. 42 (6): 607–13. doi:10.1111/j.1445-5994.2012.02752.x. PMID 22372964. S2CID 10937124.
- ↑ ABC Classic FM, Mornings with Margaret Throsby, Interview with Emeritus Professor Robert Clancy, Tuesday 30 March 2010, http://www.abc.net.au/classic/throsby/stories/s2856046.htm
- ↑ https://www.newcastle.edu.au/profile/robert-clancy
- ↑ "Biotechnology Innovation". biotechnology-innovation.com.au. Archived from the original on 19 July 2008.
- ↑ "It's an Honour - Honours - Search Australian Honours". www.itsanhonour.gov.au.
- ↑ https://www.newcastle.edu.au/profile/robert-clancy
- ↑ Parris, Michael (3 February 2021). "Vice-chancellor Alex Zelinsky says Newcastle University professor backing Liberal MP Craig Kelly's COVID-19 claims 'not an expert'". Newcastle Herald.
- ↑ https://quadrant.org.au/opinion/covidiocy/2022/11/the-problem-with-the-covid-narrative/
- ↑ Dr. John Campbell 2024, Vaccine Injury Doctor, Available at: https://m.youtube.com/watch?v=lqjYmu93sFg&t=235s&pp=ygUnZHIuIGpvaG4gY2FtcGJlbGwgdmFjY2luZSBpbmp1cnkgZG9jdG9y
| International | |
|---|---|
| National | |
| Other | |
